Literature DB >> 25470197

A preventable cancer.

Lucas Laursen.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25470197     DOI： 10.1038/516S2a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

Review 1.  Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies.

Authors:  Yi Chen; Xiaolin Wang; Jianhua Wang; Zhiping Yan; Jianjun Luo
Journal:  Eur J Cancer       Date:  2012-03-23       Impact factor: 9.162

2.  Emerging trends in hepatocellular carcinoma incidence and mortality.

Authors:  Basile Njei; Yaron Rotman; Ivo Ditah; Joseph K Lim
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

3.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

4.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

5.  Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.

Authors:  Ragaa E Omer; Anneleen Kuijsten; Abdelgadir M Y Kadaru; Frans J Kok; Mohammed O Idris; Ibrahim M El Khidir; Pieter van 't Veer
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

Review 6.  Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.

Authors:  D M Parkin; H Ohshima; P Srivatanakul; V Vatanasapt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Nov-Dec       Impact factor: 4.254

Review 7.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

8.  Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.

Authors:  Thomas J Peto; Maimuma E Mendy; Yamundow Lowe; Emily L Webb; Hilton C Whittle; Andrew J Hall
Journal:  BMC Infect Dis       Date:  2014-01-07       Impact factor: 3.090

9.  National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Authors:  Faruque Ahmed; Joseph F Perz; Sandy Kwong; Patricia M Jamison; Carol Friedman; Beth P Bell
Journal:  Prev Chronic Dis       Date:  2008-06-15       Impact factor: 2.830

10.  Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies.

Authors:  S C Larsson; A Wolk
Journal:  Br J Cancer       Date:  2007-08-14       Impact factor: 7.640
View more
  48 in total

1.  Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors.

Authors:  Zhuo Cheng; Zhiying He; Yongchao Cai; Cheng Zhang; Gongbo Fu; Hengyu Li; Wen Sun; Changcheng Liu; Xiuliang Cui; Beifang Ning; Daimin Xiang; Tengfei Zhou; Xiaofeng Li; Weifen Xie; Hongyang Wang; Jin Ding
Journal:  Cell Res       Date:  2018-12-18       Impact factor: 25.617

Review 2.  Mechanisms of liver fibrosis and its role in liver cancer.

Authors:  Debanjan Dhar; Jacopo Baglieri; Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-10

Review 3.  Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Yongjun Tian; Jing-hsiung James Ou
Journal:  Virol Sin       Date:  2015-04-07       Impact factor: 4.327

4.  Dietary Broccoli Lessens Development of Fatty Liver and Liver Cancer in Mice Given Diethylnitrosamine and Fed a Western or Control Diet.

Authors:  Yung-Ju Chen; Matthew A Wallig; Elizabeth H Jeffery
Journal:  J Nutr       Date:  2016-02-10       Impact factor: 4.798

Review 5.  MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.

Authors:  Arwa Al-Rugeebah; Mohammed Alanazi; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2019-02-21       Impact factor: 3.201

6.  miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.

Authors:  Caifeng Liu; Jun Li; Wei Wang; Xingyang Zhong; Feng Xu; Junhua Lu
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

Review 7.  Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.

Authors:  Michael Karin; Debanjan Dhar
Journal:  Carcinogenesis       Date:  2016-05-04       Impact factor: 4.944

8.  Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.

Authors:  Asmaa M Zahran; Helal F Hetta; Amal Rayan; Abeer Sharaf Eldin; Elham Ahmed Hassan; Hussein Fakhry; Ahmed Soliman; Omnia El-Badawy
Journal:  Cancer Immunol Immunother       Date:  2020-03-13       Impact factor: 6.968

9.  The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma.

Authors:  Yanli Ren; Jinhua Shang; Jinliang Li; Wenjuan Liu; Zhao Zhang; Jupeng Yuan; Ming Yang
Journal:  J Biol Chem       Date:  2017-09-08       Impact factor: 5.157

10.  Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.

Authors:  Liangfang Yao; Yang Xuan; Haiyang Zhang; Bo Yang; Xinglong Ma; Tianzhen Wang; Tianyuan Meng; Wenshe Sun; Haibin Wei; Xueqing Ma; Robb Moses; Jianru Xiao; Pei Zhang; Chao Ge; Jinjun Li; Lei Li; Xiaotao Li; Jinbao Li; Bianhong Zhang
Journal:  Oncogene       Date:  2020-11-23       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.